Bortezomib plus CHOP for the treatment of HIV-associated plasmablastic lymphoma: clinical experience in three patients.

Fernandez-Alvarez, Ruben; Gonzalez-Rodriguez, Ana P; Rubio-Castro, Arturo; Gonzalez, M Esther; Payer, Angel Ramirez; Alonso-Garcia, Ana; Rodriguez-Villar, Diana; Dominguez-Iglesias, Francisco; Sancho, Juan M

Fernandez-Alvarez, Ruben; Gonzalez-Rodriguez, Ana P; Rubio-Castro, Arturo; Gonzalez, M Esther; Payer, Angel Ramirez; Alonso-Garcia, Ana; Rodriguez-Villar, Diana; Dominguez-Iglesias, Francisco; Sancho, Juan M.

Afiliação

Fernandez-Alvarez R; a Hematology Department , Hospital de Cabueñes , Gijon , Spain.
Gonzalez-Rodriguez AP; b Hematology Department , Hospital Central de Asturias , Oviedo , Spain.
Rubio-Castro A; a Hematology Department , Hospital de Cabueñes , Gijon , Spain.
Gonzalez ME; a Hematology Department , Hospital de Cabueñes , Gijon , Spain.
Payer AR; b Hematology Department , Hospital Central de Asturias , Oviedo , Spain.
Alonso-Garcia A; c Hematology Department , Hospital Valle del Nalon , Langreo , Spain.
Rodriguez-Villar D; a Hematology Department , Hospital de Cabueñes , Gijon , Spain.
Dominguez-Iglesias F; a Hematology Department , Hospital de Cabueñes , Gijon , Spain.
Sancho JM; d Hematology Department, ICO-Hospital Germans Trias i Pujol , Jose Carreras Research Institute, Badalona, Universitat Autonoma de Barcelona , Spain.

Leuk Lymphoma ; 57(2): 463-466, 2016 Feb.

Article em En | MEDLINE | ID: mdl-25976108

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google